View of Changes in Cardiovascular Risk-Factor Profiles among Patients with Type 2 Diabetes Mellitus Receiving Dapagliflozin and Valsartan: A Prospective Observational Cohort Study

Return to Article Details Changes in Cardiovascular Risk-Factor Profiles among Patients with Type 2 Diabetes Mellitus Receiving Dapagliflozin and Valsartan: A Prospective Observational Cohort Study Download Download PDF